Exact Mass: 173.0718
Exact Mass Matches: 173.0718
Found 120 metabolites which its exact mass value is equals to given mass value 173.0718,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
N-Acetyl-L-glutamate 5-semialdehyde
N-Acetyl-L-glutamate 5-semialdehyde is an intermediate in Urea cycle and metabolism of amino groups. N-Acetyl-L-glutamate 5-semialdehyde is the. second to last step in the synthesis of L-Ornithine and is converted. from N-Acetyl-L-glutamate 5-phosphate via the enzyme N-acetyl-gamma-glutamyl-phosphate reductase (EC 1.2.1.38). It is then converted to N-Acetylornithine via the enzyme acetylornithine aminotransferase (EC 2.6.1.11). N-Acetyl-L-glutamate 5-semialdehyde is an intermediate in Urea cycle and metabolism of amino groups. N-Acetyl-L-glutamate 5-semialdehyde is the
2-Oxoarginine
2-Oxoarginine is a guanidino compound metabolite of arginine catabolism. 2-Oxoarginine levels are increased in patients with argininemia (OMIM:207800). Argininemia, characterized by arginase deficiency (EC 3.5.3.1, catalyzes the last step of the urea cycle) is an autosomal recessive inborn error of metabolism caused by a defect in the final step in the urea cycle, the hydrolysis of arginine to urea and ornithine. Accumulation of arginine metabolites (such as guanidino compounds) especially 2-oxoarginine, may produce the central nervous system damage in argininemia. (PMID: 3433275 , 1588833 , 1690873 , 819629). 2-Oxoarginine has also been identified as a uremic toxin according to the European Uremic Toxin Working Group (PMID: 22626821). 2-Oxoarginine is a guanidino compound metabolite of arginine catabolism. 2-Oxoarginine levels are increased in patients with argininemia (OMIM:207800). Argininemia, characterized by arginase deficiency (EC 3.5.3.1, catalyzes the last step of the urea cycle) is an autosomal recessive inborn error of metabolism caused by a defect in the final step in the urea cycle, the hydrolysis of arginine to urea and ornithine. Accumulation of arginine metabolites (such as guanidino compounds) especially 2-oxoarginine, may produce the central nervous system damage in argininemia. (PMID: 3433275, 1588833, 1690873, 819629) [HMDB]
Triethylenephosphoramide
D009676 - Noxae > D000477 - Alkylating Agents D000970 - Antineoplastic Agents
(1r,3r)-1-Aminocyclopentane-1,3-dicarboxylic acid
D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D020011 - Protective Agents trans-ACPD, a metabotropic receptor agonist, produces calcium mobilization and an inward current in cultured cerebellar Purkinje neurons.
Me glycoside-alpha-D-Pyranose-4-Amino-2,3,4-trideoxy-erythro-hex-2-enuronic acid
(S)-4,5,6,7-TETRAHYDRO-1H-INDAZOL-5-AMINE HYDROCHLORIDE
2,5-dibromopiperidine
Cis-piperidine-2,3-dicarboxylic acid is a non-specific antagonist of NMDA, AMPA and kainate ionotropic receptors and a partial agonist for NMDA receptors. Cis-piperidine-2,3-dicarboxylic acid can be used in blocking general excitatory synaptic transmissions[1].
4,5,6,7-Tetrahydro-2H-indazol-3-ylaMine dihydrochloride
(1R,2S,6R,7S)-4,4-DIMETHYL-3,5-DIOXA-8-AZATRICYCLO[5.2.1.0(2,6)]DECAN-9-ONE
Oxaceprol
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018501 - Antirheumatic Agents D003879 - Dermatologic Agents D - Dermatologicals
1,4,5,6,7,8-hexahydropyrazolo[3,4-d]azepine,hydrochloride
7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline
4-Pyrimidinamine,N-ethyl-2,6-difluoro-5-methyl-(9CI)
7-BROMO-1,2,3,4-TETRAHYDROISOQUINOLINEHYDROCHLORIDE
(+/-)-1-aminocyclopentane-cis-1,2-dicarboxylic acid
1-(2-Hydroxyethyl)-5-oxopyrrolidine-3-carboxylic acid
(2S,5R)-5-(Carboxymethyl)pyrrolidine-2-carboxylic acid
(2R,5R)-5-(carboxymethyl)pyrrolidine-2-carboxylic acid
4,7-Dimethylpyrazolo[5,1-c][1,2,4]triazine-3-carbonitrile
Triethylenephosphoramide
D009676 - Noxae > D000477 - Alkylating Agents D000970 - Antineoplastic Agents
5-guanidino-2-oxopentanoic acid zwitterion
Zwitterionic form of 5-guanidino-2-oxopentanoic acid.
2-Acetamido-5-oxopentanoic acid
A glutamic semialdehyde that is L-glutamate 5-semialdehyde in which one of the hydrogens of the amino group has been replaced by an acetyl group.
5-Guanidino-2-oxopentanoic acid
A 2-oxo monocarboxylic acid that is 2-oxopentanoic acid in which one of the methyl hydrogens is substituted by a carbamimidamido group.
(5S)-5-(carboxymethyl)-L-proline
A L-proline derivative that is L-proline substituted at position 5 by a carboxymethyl group.
α-keto-δ-guanidino-valericacid
{"Ingredient_id": "HBIN015573","Ingredient_name": "\u03b1-keto-\u03b4-guanidino-valericacid","Alias": "NA","Ingredient_formula": "C6H11N3O3","Ingredient_Smile": "C(CC(=O)C(=O)O)CN=C(N)N","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "12196","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
